Kiora Pharmaceuticals Inc expected to post a loss of 23  cents a share - Earnings Preview

Kiora Pharmaceuticals

25/03/2022 21:06

* Kiora Pharmaceuticals Inc  KPRX.OQ   KPRX.O  is expected
to show
a fall in quarterly revenue when it reports  results on March 27
(estimated). 
    * ​Refinitiv's mean analyst estimate for Kiora
Pharmaceuticals Inc
is for a loss of 23 cents per share. For the same quarter last
year, the company reported a loss of 52 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $7.25​, above​ its last closing price
of $0.69. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.33       -0.34      -0.29     Beat    13.9
 Jun. 30 2021  -0.41       -0.42      -0.35     Beat    16
 Mar. 31 2021  -0.39       -0.38      -0.37     Beat    3.9​
 Dec. 31 2020  -0.44       -0.44      -0.52     Missed  -18.2
 ​​Sep.        -0.42       -0.42      -0.44     Missed  -4.8
 30 2020                                                
 Jun. 30 2020  -0.43       -0.43      -0.38     Beat    11.6​
 Dec. 31 2019  -0.81       -0.81      -0.71     Beat    11.7
 This summary was machine generated March 25 at 21:05 GMT.  All
figures in US dollars  unless otherwise stated